Identification of region-specific transcription factor genes in the adult mouse brain by medium-scale real-time RT-PCR  by Suzuki, Harukazu et al.
FEBS Letters 573 (2004) 214–218 FEBS 28729Identiﬁcation of region-speciﬁc transcription factor genes in the
adult mouse brain by medium-scale real-time RT-PCRHarukazu Suzukia,b,*, Rie Okunishia,b, Wataru Hashizumea,b, Shintaro Katayamaa,b,
Noriko Ninomiyaa,b, Naoki Osatoa,b, Kenjiro Satoa,b, Mari Nakamuraa,b, Juri Iidaa,b,
Mutsumi Kanamoria,b, Yoshihide Hayashizakia,b
aLaboratory for Genome Exploration Research Group, RIKEN Genomic Sciences Center (GSC), 1-7-22,
Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan
bGenome Science Laboratory, RIKEN, 2-1 Hirosawa, Wako 351-0198, Japan
Received 9 June 2004; revised 26 July 2004; accepted 27 July 2004
Available online 11 August 2004
Edited by Takashi GojoboriAbstract We established a medium-scale real-time RT-PCR
system focusing on transcription factors and applied it to their
expression proﬁles in the adult mouse 11 brain regions (http://
genome.gsc.riken.jp/qRT-PCR/). Almost 90% of the examined
genes showed signiﬁcant expression in at least one region. We
successfully extracted 179 region-speciﬁc genes by clustering
analysis. Interestingly, the transcription factors involved in the
development of the pituitary were still expressed in the adult
pituitary, suggesting that they also play important roles in
maintenance of the pituitary. These results provide unique
molecular markers that may account for the molecular basis of
the unique functions of speciﬁc brain regions.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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factor1. Introduction
The mammalian brain is a highly complex organ, where
many unique functions are performed in discrete regions. Ex-
ploration of the molecular basis of these unique functions is a
great challenge in neurobiology. Recent advances in genomic
science, in both large-scale genomic- and cDNA-sequencing
projects, have provided information on complete sets of genes
in mammals such as humans, mice, and rats [1–8]. Such
structural information enables us to systematically analyze the
functional properties of genes, even in the complex tissues of
the mammalian brain.
Gene expression is one of the most important analyses
performed in functional studies of the brain. DNA microarray
analysis – both cDNA- and oligo-microarray – has been ex-
tensively applied to the exploration of global expression pro-
ﬁles in many organisms, and enables several tens of thousands
of genes to be searched on one chip at one time. Many ex-
cellent studies using microarray technology have been reported
in a wide variety of ﬁelds, including brain research [9–11].
However, application of the DNA microarray to the complex* Corresponding author. Fax: +81-45-503-9216.
E-mail address: rgscerg@gsc.riken.jp (H. Suzuki).
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
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sensitivity limit of the DNA microarray has been estimated to
be 1–10 copies/cell [12], whereas many transcripts that are
important for brain functions are expressed at lower levels or
in a relatively small number of cells. An evaluation of DNA
microarray sensitivity in rat hippocampal tissue showed that
the sensitivity is not high enough for reliable detection of low-
abundance transcripts [13]. Further, especially in cDNA mi-
croarrays, cross-hybridization may occur among homologous
family genes, inhibiting detection of the expression proﬁles of
speciﬁc genes in homologous gene families [14].
Real-time RT-PCR is a highly sensitive and speciﬁc method
that is widely used to explore gene expression and utilizes
several detection chemistries [15,16]. Direct detection of am-
pliﬁed double-stranded DNA is carried out by chemical
methods with ﬂuorescent dyes such as SYBR Green I. Al-
though such ﬂuorescent dyes bind to any ampliﬁed double-
stranded DNA, including non-speciﬁc double-stranded DNA,
the speciﬁcity of the test can be checked by the dissociation
curve of PCR products after ampliﬁcation, in which the am-
pliﬁed fragment is conﬁrmed to be unique. Real-time RT-PCR
is generally applied to several target genes of interest at one
time although a high-throughput detection instrument that uses
384-well assay plates is now commercially available [15,16].
Here, we report the exploration of gene expression proﬁles
of several hundred genes in diﬀerent regions of the mouse
brain using a medium-scale real-time RT-PCR system. We
selected transcription factors as target genes of interest, be-
cause transcription factors play central roles in the complex
regulation of gene expression.2. Materials and methods
2.1. Preparation of gene-speciﬁc PCR primers
We constructed a list of genes for mouse transcription factors in
accordance with the TRANSFAC public database (version 7.4; [17]).
For the list, we collected genes for both transcription factors of DNA-
binding properties and their regulation factors. We also added several
related genes from the RIKEN mouse full-length cDNA collection,
according to the annotation information of the FANTOM2 database
[5] and the InterPro domain information [18].
Gene-speciﬁc primer pairs were designed using Primer3 software
[19], with an optimal primer size of 20 bases, ampliﬁcation size of 140
bp, and annealing temperature of 60 C. The primer pairs wereblished by Elsevier B.V. All rights reserved.
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uniqueness of the designed primer pairs was checked by a BLAST
homology search (http://www.ncbi.nlm.nih.gov/BLAST/) so that ho-
mologous genes were not cross-ampliﬁed by the same primer pair.
2.2. RNA preparation and ﬁrst-stranded cDNA synthesis
Eleven-week-old male C57BL/6J mice were killed according to the
Institute’s guidelines and the whole brain was removed. The brain,
cooled in ice-cold saline, was dissected within 20 min into 11 regions:
anterior and posterior cerebral cortices, cerebellum, hippocampus,
hypothalamus, medulla oblongata, midbrain, olfactory bulb, pituitary
gland, striatum, and thalamus. Total RNA was extracted by the acid
phenol–guanidinium thiocyanate–chloroform method [20] and was
checked by agarose gel electrophoresis. Total RNA (50 lg) was sus-
pended in 100 ll of RNase-free H2O with 1 mM MgCl2 solution at
ﬁnal concentration. The RNA solution was centrifuged at 12 000 g
for 3 min and the supernatant was moved to another micro tube; this
was an essential step in the complete removal of contaminated genomic
DNA by the following DNase I treatment. RNA was treated with 25 U
of DNase I (Stratagene) at 37 C for 30 min, followed by heat inac-
tivation of the enzyme at 70 C for 10 min. Complete removal of the
contaminated genomic DNA was conﬁrmed by real-time PCR (de-
scribed below), using the PCR primer pairs for three ubiquitously
expressed genes in every sample (glyceraldehyde-3-phosphate dehy-
drogenase (GADPH), b2-macro globulin (b2m), and phosphoglycerate
kinase (Pgk1)). First-stranded cDNA synthesis (5 lg total RNA per
20-ll reaction) was carried out with the ThermoScript RT-PCR Sys-
tem (Invitrogen), in accordance with the manufacturer’s protocol.
2.3. Real-time PCR
PCR ampliﬁcation, triplicate in each sample, was carried out with an
ABI Prism 7900HT instrument (Applied Biosystems). The tailor-made
reaction (20 ll) on the 384-well plates was as follows: 0.5 U of HotStar
Taq DNA polymerase (Qiagen) and its attached 1 ampliﬁcation
buﬀer, additional 1 mM MgCl2, 160 lM dNTPs, 1/38 000 SYBR
Green I (Molecular Probes), 7% DMSO, 0.4% ROX Reference Dye
(Invitrogen), 300 nM of each primer (forward and reverse), and 2 ll of
40-fold diluted ﬁrst-stranded cDNA synthesis reaction mixture. The
polymerase activation step at 95 C for 15 min was followed by 40
cycles of 15 s at 94 C, 30 s at 60 C, and 30 s at 72 C. The dissociation
curve analysis, which evaluates each PCR product to be ampliﬁed from
single cDNA, was carried out in accordance with the manufacturer’s
protocol. Several PCR products were also checked by agarose gel
electrophoresis (data not shown).Fig. 1. Global insights into the expression proﬁles of transcription factor g
HOPACH program. Gene expressions with Ct values from 30 to 17 appear
enriched in the pituitary, cerebellum, and medulla. (B) Phylogenic tree of the2.4. Data analysis
Data were analyzed for each 384-well plate. We ﬁrst made 384
ampliﬁcation plots, in which the ﬂuorescence signal detected was
plotted against the PCR cycle. The ampliﬁcation curves with the top
10–50% of ﬂuorescence signals in the plateau phase were used to cal-
culate the mean ﬂuorescence signal in this phase. The threshold was
empirically set as 4% of the value of the mean ﬂuorescence signal. We
then calculated each threshold cycle (Ct) value from the 384 plots.
Clustering of expression proﬁles was carried out with the HOPACH
program (http://stat-www.berkeley.edu/~laan/Research/Research_sub-
pages/Papers/hopach.pdf) with Euclidean dissimilarity metric. Genes
speciﬁcally expressed in brain regions were selected as follows. We ﬁrst
removed genes that had Ct values larger than 30 in all 11 brain regions,
because Ct values more than 30 are less-reliable due to large variations
in the reproducibility test (data not shown). Then, we selected genes
whose Ct values in some brain regions were 2.5 cycles smaller than the
average Ct values of all 11 brain regions. This meant that the level of
expression in some regions was ideally more than 5.6-fold higher than
the average expression. Finally, we calculated the deviation values of
each Ct value for the 11 brain regions and selected genes that had
deviation scores of more than 60 in at least one region.3. Results
3.1. Expression proﬁles of transcription factor genes in adult
mouse brain regions
To detect the levels of mRNA expression for several hundred
transcription factor genes, we have established a medium-scale
real-time RT-PCR system that used a tailor-made reaction with
SYBR Green I dye as a detector of PCR products. Using the
system, we constructed the expression proﬁles of 756 tran-
scription factor genes (http://genome.gsc.riken.jp/qRT-PCR/).
A high percentage of transcription regulation factors seems to
be expressed in adult mouse brain: 543–612 genes (72–81%)
showed Ct values less than 30 (corresponding to 69.7 copies/
reaction, as estimated from the standard curves) in each brain
region. Further, 677 genes (89.6%) showed Ct values less than
30 in at least one brain region, reﬂecting the high complexity of
mouse brain tissues. Next, we clustered the expression proﬁles,enes in adult mouse brain regions. (A) Clustering analysis using the
as light red to red. The blue, light green, and pink bars show genes
11 brain regions, based on the expression of transcription factor genes.
Fig. 2. Region-speciﬁc genes identiﬁed by the medium-scale real-time RT-PCR system. The 11 dissected brain regions and their abbreviated names
are schematically represented in the line diagram. The brain regions and numbers of region-speciﬁc genes are shown above each column. In the
columns, region-speciﬁc genes are shown in the order of smaller to larger deviation score. Light pink, pink, and dark pink represent deviation scores
of 60.0–64.9, 65.0–69.9, and 70.0 and above, respectively.
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scription factor gene expression (Fig. 1A). All 11 brain regions
examined had similar expression proﬁles, although several
genes seemed to be expressed in a region-speciﬁc manner. TheTable 1
Conﬁrmation of cerebellum-speciﬁc transcription factor genes identiﬁed by r
Locus ID Gene Name Dev.
15207 Hes3 77.8
17121 Mad3 76.4
18012 Neurod1 75.2
21418 Tcfap2a 73.4
13799 En2 72.1
22772 Zic2 70.3
22771 Zic1 69.2
22255 Uncx4.1 68.6
18505 Pax3 68.2
243187 E130309B19 68.1
54422 Barhl1 67.9
21419 Tcfap2b 67.7
16869 Lhx1 66.6
23957 Nr0b2 66.2
13592 Ebf2 65.2
16873 Lhx5 64.4
18292 Og9x 64.0
18013 Neurod2 61.7
We selected 18 prominent cerebellum-speciﬁc genes whose Ct values were m
regions (see http://genome.gsc.riken.jp/qRT-PCR/). We used PubMed (http
‘cerebellum’, ‘expression’, and the gene name (e.g. ‘Hes3’), and then manually
used to elicit cerebellum-speciﬁc expression of the target genes are shown in
‘immunohistochemistry’; ‘n.r.’, ‘not reported’. * The alternatively spliced for
suggested from the embryonic expression pattern.phylogenic tree of the brain regions, with the exception of the
pituitary gland, which includes cells derived from early ecto-
derm (see below), seemed to be consistent with the development
of each brain region (Fig. 1B); the regions derived from theeal-time RT-PCR
Ct Methods Refs.
20.9 Northern [38]
28.3 n.r.
18.7 SAGE [39]
24.2 ISH [40]
21.0 n.r.
20.9 Northern, SAGE [27,39]
19.5 Northern [28]
22.8 n.r.
25.1 RT-PCR* [41]
21.8 n.r.
25.6 ISH** [29]
22.3 n.r.
21.2 ISH, IH [30]
27.0 n.r.
25.0 RNAse protection [31]
28.9 RT-PCR [42]
24.3 ISH [32]
20.7 Northern, ISH [43]
ore than 4.0 cycles smaller than the average Ct values of all 11 brain
://www.ncbi.nlm.nih.gov/) to search the literature using the keywords
collated the results. The Section 2 and the literature references (Refs.)
the Table. ‘Dev.’, ‘deviation score’; ‘ISH’, ‘in situ hybridization’; ‘IH’,
m of Pax3A is expressed in a cerebellum-speciﬁc manner. ** Strongly
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ior cerebral cortices, striatum, and hippocampus), the dien-
cephalons and mesencephalon (thalamus, hypothalamus, and
midbrain), and metencephalon and myelencephalon (cerebel-
lum and medulla oblongata) were clustered well.
3.2. Analysis of region-speciﬁc genes
We selected genes whose expression was enriched in a re-
gion-speciﬁc manner; this resulted in the identiﬁcation of 179
genes (Fig. 2, and http://genome.gsc.riken.jp/qRT-PCR/). Such
region-speciﬁc genes were observed frequently in the medulla
oblongata, cerebellum, pituitary gland, and midbrain, but less
often in the posterior cerebral cortex and hippocampus. In
particular, transcription factor genes with high deviation
scores (>70; shown in dark pink in Fig. 2), which suggest
highly region-speciﬁc expression, were found frequently in the
medulla oblongata and the pituitary gland. To evaluate our
ﬁndings, we selected 18 cerebellum-speciﬁc genes that exhibited
prominent cerebellum-speciﬁc expression in our experiments
and searched the literature to ﬁnd out whether they had al-
ready been identiﬁed as cerebellum-speciﬁc genes. In the lit-
erature, 12 of the 18 genes had been conﬁrmed, or were
strongly suspected, as being cerebellum-speciﬁc (Table 1).
We further analyzed genes enriched in the pituitary, because
several transcription regulation factors are well known to be
involved in pituitary development [21,22]. The mammalian
pituitary is an endocrine organ consisting of several types of
secretory cells; each type of cell secretes a unique peptide
hormone. These cell types are derived from a common origin in
the early ectoderm. Our results showed that most of the tran-
scription factors involved in the development and diﬀerentia-
tion of each type of secretory cell are still expressed speciﬁcally
in the adult pituitary gland (pink columns in Fig. 3). The re-Fig. 3. Detection of the transcription factors regulating anterior pitu-
itary gland development. This ﬁgure was made by referring the ﬁgure
from [22]. After interaction with the ventral diencephalons (DIEN),
oral ectoderm (OE) forms Rathke’s pouch and then diﬀerentiates into
several hormone-secreting cell types (shown in ellipses). Many tran-
scription factors (shown in the colored columns) have been known to
act throughout development of the pituitary. Transcription factors
that showed and did not show pituitary-speciﬁc expression in our real-
time RT-PCR studies are marked with pink and light blue columns,
respectively. Gata2 showed pituitary-enriched expression, but was not
considered in our criteria as a region-speciﬁc gene (see Section 2 and
http://genome.gsc.riken.jp/qRT-PCR/). Transcription factors that
could not be explored in our studies are shown in gray columns.sults suggest that such transcription factors play important
roles in both the development and maintenance of secretory
cells in the pituitary. Interestingly, we observed that expression
of the Nr1h3 and Nr1h4 genes, known as activators of retinoic
acid receptor (RAR) [23–25], was greatly enriched in the pi-
tuitary, although RAR mRNA, which is involved in somato-
trope diﬀerentiation, is expressed in both the pituitary and
other brain regions (http://genome.gsc.riken.jp/qRT-PCR/).
The result suggests that Nr1h3 and Nr1h4 play critical roles as
determinants of somatotrope diﬀerentiation (and also mainte-
nance of somatotrophs) by regulating RAR activity.4. Discussion
We successfully identiﬁed 179 region-speciﬁc genes and
conﬁrmed that the expression of several of them was consistent
with data in previous reports, thus showing that our results
were reliable. Several regions of the adult brain, such as the
posterior cerebral cortex and hippocampus, had relatively few
region-speciﬁc transcription factor genes. However, this may
be biased by the eﬀect of normalization, whereby genes highly
expressed in a small area and/or a small number of cells in a
particular dissected region may have been buried and thus not
detected as region-speciﬁc genes. Thus, real-time RT-PCR
analysis of more restricted brain regions and/or groups of cells
may be valuable for further identiﬁcation of region-speciﬁc
genes. In fact, both here (data not shown) and in a previous
report [26], we successfully detected Nr2f2 as an amygdala-
speciﬁc transcription factor by real-time RT-PCR, although
Nr2f2 was not identiﬁed in our experiments as a region-speciﬁc
gene of the anterior cerebral cortex, with which the amygdala
is involved. We also stress that the identiﬁed region-speciﬁc
genes should be further explored by other methods such as in
situ hybridization. Together with the need to conﬁrm our re-
sults, it is very important to explore whether the expression of
these genes is spatially localized in speciﬁc nuclei and/or cells in
the dissected region.
We found that most of the transcription factors involved in
the development and diﬀerentiation of each type of secretory
cell in the pituitary were still expressed in a region-speciﬁc
manner in the adult pituitary. This observation seems to be
applicable to other brain regions such as cerebellum [27–32].
Region-speciﬁc transcription factor genes may be good clues to
our understanding of tissue development and functions. Be-
cause current chromatin immunoprecipitation (ChIP) tech-
nology allows us to identify the interaction loci of each
transcription factor on the genomic DNA, it is possible to
draw transcription regulation motifs and pathways by inte-
grating the expression proﬁles with data from ChIP analysis,
and thus show how transcription factors are regulated by one
another [33,34]. Further, as we showed that Nr1h3 and Nr1h4
may be involved in somatotrope diﬀerentiation through RAR,
it will also be useful to integrate the expression proﬁles with
protein–protein interaction data, because most of the tran-
scription factors act as homo- and hetero-dimers and are
regulated by direct interaction with a variety of modulating
factors. Finally, ChIP analysis may also disclose the target
genes of region-speciﬁc transcription factors, which may also
lead to identiﬁcation of novel region-speciﬁc genes that play
important roles in the functioning of brain regions.
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pression proﬁles can also be analyzed to ﬁnd novel transcrip-
tion factor genes involved in regionalization of the brain,
where they are expressed in relatively large regions such as
forebrain, midbrain or hindbrain rather than one of the 11
dissected regions. So far, more than 10 transcription factor
genes have been identiﬁed as genes controlling regionalization
of the brain such as En1 and 2, Pax2, 5 and 6, Emx1 and 2,
Dlx1 and 2, Otx1 and 2, Gsh2 and Gbx2 [35–37]. We found in
our data that all the genes, except for Pax6, are still expressed
distinctively in adult brain. Remarkably, we discovered that
many genes, for example Lhx gene family, also exhibit similar
expression patterns to those of genes described above. Thus, it
is a very attractive way to explore the function of such genes
with regard to the regionalization of the brain.
This medium-scale real-time RT-PCR system seems valuable
for expression proﬁle analysis of highly complex tissues such as
the brain and/or relatively sparsely distributed transcript fam-
ilies such as transcription factors, although the system is basi-
cally applicable to all tissues. In addition, the system may be
suitable for exploring the dynamic expression of genes during
diﬀerent developmental stages and/or conditions, such as dur-
ing drug treatment. The system is almost ready for general use,
although the primer sets for mouse transcription factors are still
not complete. The major reason is that there is no compre-
hensive non-redundant transcription factor list in the mouse.
Recently, we have started to construct a genome-wide, non-
redundant mouse transcription factor list, which will provide us
with additional transcription factor genes to be explored.
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